
Emitin 1mg/ml Suspension
Marketer
Cachet Pharmaceuticals Pvt Ltd
Salt Composition
Domperidone (1mg/ml)
Overview Emitin 1mg/ml Suspension
PediaGast 1mg/ml oral suspension aids in managing indigestion, gastroesophageal reflux, nausea, and vomiting in pediatric patients. It accelerates gastric emptying and intestinal transit, alleviating symptoms like bloating, satiety, and stomach upset. Administer PediaGast 1mg/ml thirty minutes prior to meals for optimal efficacy. Post-prandial administration remains effective, though absorption might be slightly reduced. Infants may receive a physician-prescribed four-times-daily regimen, ideally before each feeding, with at least a four-hour interval between doses. Dosage is individualized based on the child's age, weight, and condition. Never extend treatment beyond the prescribed period without consulting a doctor. If vomiting occurs within 30 minutes of ingestion, repeat the dose after the child has settled; however, avoid doubling if the next dose is imminent. Minor, transient side effects such as dry mouth, headache, somnolence, abdominal cramping, and diarrhea may occur, typically resolving with continued use. Persistent or troublesome side effects warrant immediate medical attention. Inform your child's physician of any prior allergies, cardiac conditions, hematological disorders, congenital anomalies, respiratory issues, gastrointestinal problems, dermatological conditions, hepatic impairment, or renal dysfunction. A complete medical history facilitates precise dosage adjustments and optimal treatment planning.
Uses of Emitin 1mg/ml Suspension
Managing acid reflux and gastroesophageal reflux disease (GERD)|Relieving indigestion symptoms|Addressing nausea|Treating vomiting
Major Benefits of Emitin 1mg/ml Suspension:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Always consult the product label for usage instructions prior to consumption. Use a measuring device for accurate dosing and ingest orally. Ensure thorough shaking before each use. Consume Emitin 1mg/ml Suspension on an empty stomach.
Common Side effects of Emitin 1mg/ml Suspension:
- Dryness in mouth
- Headache
- Drowsiness
- Stomach cramp
- Diarrhea
How to use Emitin 1mg/ml Suspension:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Always consult the product label for usage instructions prior to consumption. Use a measuring device to accurately dispense the oral dose. Ensure thorough shaking before each use. Consume Emitin 1mg/ml Suspension on an empty stomach.
How Emitin 1mg/ml Suspension works:
Reglan 1mg/ml oral suspension stimulates gastrointestinal motility. Its mechanism involves central action on the brain's emetic center and peripheral effects on the upper digestive tract, enhancing gastric and intestinal transit and facilitating food passage.
SAFETY ADVICE
KidneyCAUTION
For individuals with severe kidney impairment, administering Emitin 1mg/ml Suspension requires careful consideration. Dosage modification of Emitin 1mg/ml Suspension might be necessary. Physician consultation is advised. Consistent monitoring of kidney function, especially during prolonged treatment, is recommended.
LiverCAUTION
Caution is advised when administering Emitin 1mg/ml Suspension to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is recommended. Emitin 1mg/ml Suspension is unsuitable for children exhibiting severe liver dysfunction. Pediatric administration requires prior medical evaluation.
What if you forget to take Emitin 1mg/ml Suspension :
If your child's physician hasn't prescribed a different schedule, administer the omitted dose upon remembering. However, omit the dose if the next scheduled dose is imminent. Avoid doubling the dose to compensate, and adhere to the recommended medication schedule.
Facts to Know About Emitin 1mg/ml Suspension
| Label | Value |
|---|---|
| Chemical Classification | Benzimidazole-based compound |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal System |
| Actions | Prokinetic agent with dopamine D2 receptor antagonism |
